Join us for our Stem Cell Genome Editing Series, showcasing cutting-edge advances in genome editing for stem cell biology and therapeutic development. The series reflects the Center for Genome Surgery’s mission to address critical challenges in gene editing and aligns with the UCSF Broad Stem Cell Center’s vision to Discover, Engineer, Heal. This series takes place on the second and fourth Tuesday of each month (with occasional holiday adjustments) and begins with research presentations, followed by an open Q&A discussion. At our session on Jan 13, Kelsey Collins, PhD, will present “Designer cells and tissues as anti-cytokine therapies.”

Speaker Lineup
Jan 13 | Kelsey Collins “Designer cells and tissues as anti-cytokine therapies”
Jan 27 | Nadav Ahituv “Targeting gene regulatory elements for therapeutic benefits”
Feb 10 | Greg Mohl "High-throughput platforms for gene editing and delivery optimization"
Feb 24 | Serine Avagyan "Multiplex mosaic CRISPR-cas9 mutagenesis in vivo"
March 10 | Alex Marson "Decoding and Reprogramming Human T Cell Circuits with CRISPR"
March 24 | Peter Bruno "Synthetic biology to enable antigen presentation screening systems"
April 14 | Dan Wagner “Simultaneous single-cell phenotyping and genotyping in Cas9-edited genetic mosaic embryos”
April 28 | James Gardner TBA

UCSF welcomes all participants to our events. If you need a reasonable accommodation to participate in this event because of a disability, please contact IRMEvents@ucsf.edu as soon as possible.